BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17495020)

  • 1. Digoxin-like immunoreactive factors induce apoptosis in human acute T-cell lymphoblastic leukemia.
    Ihenetu K; Qazzaz HM; Crespo F; Fernandez-Botran R; Valdes R
    Clin Chem; 2007 Jul; 53(7):1315-22. PubMed ID: 17495020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammalian cardenolides in cancer prevention and therapeutics.
    Al-Ghoul M; Valdes R
    Ther Drug Monit; 2008 Apr; 30(2):234-8. PubMed ID: 18367987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of Na-K-ATPase in human urine: effects of ouabain-like factors and of vanadium-diascorbate on calcium mobilization in rat vascular smooth muscle cells: comparison with the effects of ouabain, angiotensin II, and arginine-vasopressin.
    Meyer-Lehnert H; Bäcker A; Kramer HJ
    Am J Hypertens; 2000 Apr; 13(4 Pt 1):364-9. PubMed ID: 10821337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of endogenous digitalis-like immunoreactive factors in human blood.
    Lin MH; Liao CP; Lee JS; Chin YW; Hsu CC; Wei JS
    Proc Natl Sci Counc Repub China B; 1998 Jul; 22(3):129-35. PubMed ID: 9779602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of ouabain and human ouabainlike substance to different Na+, K+-ATPase isoforms.
    Butt AN; Tennant BP; Gillingwater SD; Shepherd PS; Swaminathan R
    Hypertens Res; 2000 Sep; 23 Suppl():S45-50. PubMed ID: 11016819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythrocyte sodium pump stimulation by ouabain and an endogenous ouabain-like factor.
    Balzan S; D'Urso G; Nicolini G; Forini F; Pellegrino M; Montali U
    Cell Biochem Funct; 2007; 25(3):297-303. PubMed ID: 17191274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Criteria for identifying endogenous compounds as digoxin-like immunoreactive factors in humans.
    Lau BW; Valdes R
    Clin Chim Acta; 1988 Jun; 175(1):67-77. PubMed ID: 2844442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Digoxin and digoxin-like immunoreactive factors (DLIF) modulate the release of pro-inflammatory cytokines.
    Ihenetu K; Espinosa R; de Leon R; Planas G; Perez-Pinero A; Waldbeser L
    Inflamm Res; 2008 Nov; 57(11):519-23. PubMed ID: 19109744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous plasma Na,K-ATPase inhibitory activity and digoxin like immunoreactivity after acute myocardial infarction.
    Bagrov AYa ; Fedorova OV; Maslova MN; Roukoyatkina NI; Ukhanova MV; Zhabko EP
    Cardiovasc Res; 1991 May; 25(5):371-7. PubMed ID: 1649699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of endoxin in hypertensive patients].
    Gorjão Clara J; Breitenfeld B; Bicho M; Moreira C; Carvalho C; Boaventura I; Manso C; Nogueira da Costa J
    Rev Port Cardiol; 1991 Jan; 10(1):29-33. PubMed ID: 1647807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo biosynthesis and radiolabeling of mammalian digitalis-like factors.
    Qazzaz HM; Cao Z; Bolanowski DD; Clark BJ; Valdes R
    Clin Chem; 2004 Mar; 50(3):612-20. PubMed ID: 14981028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of an endogenous ouabain-like immunoreactive compound with digitalis-like properties in the human.
    Balzan S; Montali U; Ghione S
    Ann N Y Acad Sci; 1997 Nov; 834():626-30. PubMed ID: 9405875
    [No Abstract]   [Full Text] [Related]  

  • 13. Digoxin-like immunoreactive factor in rat plasma: effect of sodium and calcium intake.
    Doris PA
    Life Sci; 1988; 42(7):783-90. PubMed ID: 2828804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digoxin-binding antibodies reverse the effect of endogenous digitalis-like compounds on Na,K-ATPase in erythrocytes.
    Balzan S; Montali U; Biver P; Ghione S
    J Hypertens Suppl; 1991 Dec; 9(6):S304-5. PubMed ID: 1668002
    [No Abstract]   [Full Text] [Related]  

  • 15. Digoxin and its related endogenous factors.
    Jortani SA; Valdes R
    Crit Rev Clin Lab Sci; 1997; 34(3):225-74. PubMed ID: 9226105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous digoxin-like immunoreactive factor and digitalis-like factor associated with the hypertension of patients receiving multiple alkylating agents as part of autologous bone marrow transplantation.
    Graves SW; Eder JP; Schryber SM; Sharma K; Brena A; Antman KH; Peters WP
    Clin Sci (Lond); 1989 Nov; 77(5):501-7. PubMed ID: 2555106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and characterization of endogenous digoxin-like immunoreactive factors in chicken blood.
    Wei JS; Cheng HC; Tsai KJ; Liu DH; Lee HH; Chiu DT; Liu TZ
    Life Sci; 1996; 59(19):1617-29. PubMed ID: 8913327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deglycosylated products of endogenous digoxin-like immunoreactive factor in mammalian tissue.
    Qazzaz HM; Goudy SL; Valdes R
    J Biol Chem; 1996 Apr; 271(15):8731-7. PubMed ID: 8621507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum digoxin-like immunoreactive factor in children and its relation to sodium metabolism.
    Garbagnati E
    Acta Paediatr; 1998 May; 87(5):500-4. PubMed ID: 9641729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further biochemical characterization of an Na+ pump inhibitor purified from human urine.
    Crabos M; Grichois ML; Guicheney P; Wainer IW; Cloix JF
    Eur J Biochem; 1987 Jan; 162(1):129-35. PubMed ID: 3028785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.